Loading...
MON-LB83 The Initial Dose of (131)I as a Potential Independent Predictor for Residual/Relapsed Disease in Pediatric Differentiated Thyroid Cancer
Introduction: In the guidelines for management of pediatric Differentiated Thyroid Cancer (DTC) (131)I therapy is recommended for treatment of iodine-avid persistent locoregional disease that cannot be resected as well as iodine-avid distant metastases. To date, no consensus has been reached regardi...
Saved in:
| Published in: | J Endocr Soc |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7209508/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2179 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|